Divya Prakash J.’s Post

Navigating the expansive Chinese market can be daunting. That's why events like #CMEF are invaluable for UK HealthTech companies. 🤔 CMEF, the largest HealthTech expo in the region, provides direct access to one of the world's largest healthcare markets. It allows companies to efficiently showcase their products and services to a targeted audience. A special thanks to Neurovalens' Iain Hendrick for sharing how ABHI's support at CMEF has been instrumental in their journey. In Iain’s words: “Showcasing medical devices created meaningful relationships with the medical device community in China, accelerating our market access and knowledge at a cost-effective rate.” 🚀 Don’t miss Iain's expert advice on why CMEF is your gateway to market success 👇 Ready to tap into the Chinese market? Join us at CMEF 2025 and leverage exclusive benefits to position your company for growth in the Chinese healthcare market. For more details, contact [email protected]. #CMEF2025 #UKHealthTech #HealthcareInnovation #ChinaMarket #ABHIUKPavilion #GlobalExpansion

Watch this space for the launch of the Asia Pacific Medical Technology Association (APACMed) - KPMG India knowledge paper on fostering #research and #innovation in India's #medicaldevice industry. We will also share insights from a panel of esteemed industry leaders in discussion on collaboration and innovation acceleration across India's medical devices ecosystem. #innovateinindia Nikhil Patil | Vy Tran | Shishir Agarwal | Dr. Vibhav Garg | Manish Diwan | Naresh Bhatnagar

Exciting News: Gradient Health & Technologies Pte Ltd. Is Thrilled to work with Biomedica to introduce an Innovative, AI-based Osteoporosis Diagnosis solution in Singapore: Biomedica X1AI - Bone Densitometer   Dear Linkedin Community,   I am excited to share a groundbreaking advancement in healthcare with all of you! We are proud to unveil our latest innovative solution: Biomedica X1AI - Bone Densitometer - an AI-based solution for osteoporosis diagnosis that is not only approved by the Health Sciences Authority (HSA) in Singapore but has also been embraced across borders.   ✅ Accurate Diagnosis, Rapid Results: our State-of-the art AI technology allows for swift and precise osteoporosis diagnosis, providing results in a fraction of the time compared to traditional methods, all while maintaining an accuracy on par with gold-standard DEXA scans. With this breakthrough, patients can now receive the information they need faster, enabling quicker decision-making and treatment planning.   ✅ Affordable Accessibility: Health should be accessible to all. We are committed to making osteoporosis screening affordable without compromising accuracy. Our solution eliminates the financial barrier to early detection, allowing more individuals to take proactive steps towards better bone health.   ✅ User-Friendly Experience: We believe that technology should be intuitive for everyone. Our user-friendly interface ensures that the process of undergoing an osteoporosis diagnosis is simple and convenient.  No complex procedures, no unnecessary stress – just clear insights into your bone health.    At Gradient Health & Technologies, we are dedicated to pushing the boundaries of what technology can achieve for healthcare. Biomedica X1AI - Bone Densitometer is embraced internationally and a testament to our mission to improve lives and contribute to a healthier world.   Stay tuned for more updates as we continue to make strides in the field of healthcare technology. Feel free to reach out if you have any questions or would like to learn more about out solution.   Here’s to a future where bone health is easily accessible and prioritized by all, regardless of borders. Together, let’s embrace innovation for better lives as we continue to bring these Solutions in Motion.   #healthcareinnovation #osteoporosisdiagnosis #AIinHealthcare #HealthTech #HSAApproved #GlobalHealthCare #BoneHealthMatters #Biomedica

🇻🇳 Vietnam's Diagnostic Imaging Market: A Snapshot of Growth and Opportunity 📊 Did you know? Vietnam's diagnostic imaging market is on a remarkable trajectory, projected to grow at a CAGR of 5.20% through 2029. Here's why this matters: 🏥 Rising chronic diseases are driving demand for early detection and accurate diagnosis 💰 Increased healthcare spending is expanding imaging facilities, especially in urban areas 🔬 Cutting-edge tech in X-ray, CT, MRI, and more is revolutionizing diagnostics 🧠 Growing awareness of preventive healthcare is boosting the market Key players like Philips, Siemens, and FUJIFILM Holdings America Corporation are at the forefront of this revolution. But there's room for innovation and investment! Get PDF report - https://lnkd.in/gCg3h4X4 Are you in the healthcare sector? How do you see this growth impacting your business or career? TechSci Research #HealthcareTech #VietnamMarket #DiagnosticImaging #MedicalInnovation

STAY INFORMED ABOUT THE LATEST REPORT FROM 𝐈𝐧𝐭𝐞𝐥𝐥𝐞𝐜𝐭𝐮𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝟐𝟎𝟐𝟑-𝟐𝟎𝟑𝟏 COVERS 𝐁𝐲 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬, 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧𝐬 AND 𝐕𝐚𝐫𝐢𝐨𝐮𝐬 𝐑𝐞𝐠𝐢𝐨𝐧𝐬 INCLUDING:  #NorthAmerica #Europe #AsiaPacific #LatinAmerica and #Africa.   Don't miss out on this opportunity to stay informed about the latest trends in the Industry.   Global Electrophysiology Devices Market Size, Share & Trends Analysis Report By Product, By Indication, By End-Use, Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023 - 2031 IMIR Market Research Pvt. Ltd.   📚𝐆𝐞𝐭 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐀𝐭 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭𝐞𝐝 𝐏𝐫𝐢𝐜𝐞:📝👇https://lnkd.in/dXDxvWgz 📚𝐑𝐞𝐩𝐨𝐫𝐭 𝐅𝐨𝐜𝐮𝐬𝐞𝐝 𝐎𝐧 𝐓𝐨𝐩 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬: Galvanize Therapeutics, Inc. Hansen Medical Hyblate Medical Imricor Interventional Systems Japan Lifeline Co., Ltd. Johns Hopkins Medicine Philips Lepu Medical Technology (Beijing) Co., Ltd. LEPU Scientech Medical MC10 Inc. (now part of Medidata Solutions, Inc.) MedLumics, S.L. Medtronic MedWaves, Inc. Medyria MicroPort NeuroTech MicroPort Scientific India Pvt. Ltd. MicroPort Scientific India Pvt. Ltd. Molecular Devices (Danaher Corporation) NeuTrace Nihon Kohden America Novasentis, Inc OrbusNeich Medical Company Ltd. Philips Healthcare SL S4 Medical Seattle Children's Seoul National University Hospital Shanghai HeartCare Medical Technology Corporation Limited Siemens Healthcare Pvt. Ltd. Siemens Healthineers St. Louis Cardiovascular St. Jude Medical Stereotaxis Cleveland Clinic VisCardia Vivonics, Inc. Voyage Medical Zylox-Tonbridge Medical Technology Co., Ltd #ElectrophysiologyDevices 👤#Intellectualmarketinsightresearch #Marketresearchreports #Size  #Share #Trends #Growth #Opportunity #Outlook #Forecast #Covid19 #Segments #KeyPlayers #RegionsOutlook #GrowthPotential #PriceTrends #CompetitiveMarket #Forecast #2022To2028 #2023To2031

🌟 Introducing our new #MedTech ecosystem map!   🗺️ Discover the vibrant #MedicalTechnology landscape in the Greater Zurich Area with our latest map. Featuring MedTech companies, medical products & devices companies, universities and research institutions, as well as public organizations and platforms, our map provides a comprehensive overview of the key players in the region.   🔬 Why do so many MedTech companies choose the #GreaterZurichArea? The region stands out for its unique exchange of knowledge and expertise between industry-leading companies and top research institutions. This creates a remarkable synergy that fosters #innovation and drives technological breakthroughs.   🌐 This environment also attracts significant capital and #talent. Proximity to a major financial center offers excellent funding opportunities, while renowned universities draw international students and future professionals, making Greater Zurich a global talent hub.   🔍 Explore the dynamic MedTech ecosystem of the Greater Zurich Area here: https://lnkd.in/dPfCUffP. To directly download the MedTech ecosystem map, click here: https://lnkd.in/d3gk-9qZ.

Innovation in the MedTech industry thrives through cross-sector collaboration, blending academic rigor with industry expertise. This synergy fosters technological breakthroughs, making healthcare more innovative and patient-centric.

🌟 Introducing our new #MedTech ecosystem map! 🗺️ Discover the vibrant #MedicalTechnology landscape in the Greater Zurich Area with our latest map. Featuring MedTech companies, medical products & devices companies, universities and research institutions, as well as public organizations and platforms, our map provides a comprehensive overview of the key players in the region. 🔬 Why do so many MedTech companies choose the #GreaterZurichArea? The region stands out for its unique exchange of knowledge and expertise between industry-leading companies and top research institutions. This creates a remarkable synergy that fosters #innovation and drives technological breakthroughs. 🌐 This environment also attracts significant capital and #talent. Proximity to a major financial center offers excellent funding opportunities, while renowned universities draw international students and future professionals, making Greater Zurich a global talent hub. 🔍 Explore the dynamic MedTech ecosystem of the Greater Zurich Area here: https://okt.to/pBhuif. To directly download the MedTech ecosystem map, click here: https://okt.to/IAQ0MJ.

Andrew Wu, Arsen Batagov, Dr Melvin Heng, Wen Bin LAI (PhD, MBA), Stacy Y., Aditya Mathur, Andy Cheah Chor Min, Anastasia Ling, Brian Kennedy, Frank Eisenhaber, and Adrian CHUA are Transforming Healthcare Delivery with Mesh Bio's Health Intelligence Platform Mesh Bio Pte. Ltd. is revolutionizing patient care with its innovative Health Intelligence Platform, employing systems biology and predictive analytics to optimize care delivery for healthcare providers. Their platform, DARA, combines scientific data, AI analytics, and digital health strategies to enhance clinical decision support and guide interventions effectively. Key Features of Mesh Bio: Comprehensive Assessment: Over 150,000 patients have been assessed using Mesh Bio's sophisticated tools. Extensive Reach: Collaborating with 25 medical groups and utilizing over 7,000 clinical logic scenarios. Efficiency Boost: Achieving more than 90% time savings in healthcare processes. DARA's Impact: Based on proven medical science and explainable systems biology, DARA enables and enhances clinical decision support and intervention guidance, ensuring reliable and actionable solutions. Services Offered: Physicians Practice: Digital transformation of care delivery through clinical workflow automation and predictive analytics. Patient Engagement: Offering personalized disease risk predictions and health insights for better patient engagement. Pharmaceutical Development: Assisting pharmaceutical development by elucidating pharmacodynamics in complex biological systems. Chronic Disease Management: Mesh Bio excels in transforming health screening and chronic disease management for conditions like cardiovascular diseases, hypertension, diabetes, fatty liver, kidney disease, myocardial infarction, and stroke. Who They Help: Their solutions are tailor-made for healthcare providers and innovators, including healthcare groups, executive health screening centers, general practitioners, multi-disciplinary clinics, specialist clinics, and private hospitals. Partnerships and Recognition: Mesh Bio is a trusted partner in the health tech community, featured in prestigious publications, and involved with influential partners like block 71, elev8, enterprise Singapore, and startup Creasphere. Connect with Mesh Bio: Interested in learning more about how Mesh Bio can transform your healthcare services? http://www.meshbio.com Explore our ideas to maximize your time in Tokyo - https://lnkd.in/gXEPFF9B P.S. What innovations do you believe could transform the management of chronic diseases in the next few years? #HealthTech #PatientCare #MeshBio #STT2024GSP

The influx of digital and technological input into our healthcare ecosystem has created both opportunity and chaos. I take a minute to applaud those on the tip of the spear driving innovation in these unchartered waters, it has been challenging to determine best path forward. At the recent #arabhealth2024 conference, United Imaging Healthcare, announced partnerships with Prepaire Labs for advanced drug discovery and #personalizedmedicine, Al Mana Holding: Al Mana Group towards global distribution, and National Blood & Cancer Center - NBCC for training and services. Siemens Healthineers announced partnerships with LeanTaaS and Claroty extend Siemens digital capabilities. Players like Pearl Health and Story Health partner to improve treatment for #cardiovascular disease. The greatest opportunities for many technology providers in the industry will be a partnership with the strategics that already own the distribution channels. In this chat with my partners Ajay Nair and Tom Farr we discuss these important collaborations. Most medical device companies will never be, nor should they be, the source of novel digital solutions. Most digital companies are not built to make medical devices. Together, they can elevate the patient care experience.